PharmaJet Announces Addition of Melissa Malhame as VP Business enterprise Growth

Press release content material from Business enterprise Wire. The AP information team was not included in its creation.

GOLDEN, Colo.–(Organization WIRE)–Sep 29, 2020–

PharmaJet®, the maker of progressive, needle-totally free injection know-how, nowadays introduced that Melissa Malhame, has joined the management group as Vice President, Small business Improvement. Ms. Malhame is a worldwide company executive with about 25 several years of working experience in enterprise improvement, strategic revenue, and advertising and marketing for big vaccine companies these as Gavi, Dynavax and Merck, as perfectly as supporting worldwide well being investments in new vaccine candidates and increasing obtain to current vaccines. In this part she will be main company progress, gross sales, and internet marketing for the Pharmajet business.

Chris Cappello, President and CEO, PharmaJet Inc., stated, “We are pretty delighted to welcome Ms. Malhame to the PharmaJet management workforce. Her strategic company development experience with major vaccine providers, as very well as her extensive practical experience with Gavi and other key world wide health companies will aid drive the expansion and use of our Needle-absolutely free injection program technology.”

Since 1994 Ms. Malhame held important organization development and revenue roles at outstanding vaccine providers and funding corporations. As head of Marketplace Shaping at Gavi, The Vaccine Alliance, she managed $1 billion of annual vaccine funding. In that role, she set up strategies for 10 vaccine marketplaces and chilly chain machines, designed and executed a distinctive business approach for the Ebola vaccine, and created and managed associations with the WHO, UNICEF and The Monthly bill and Melinda Gates Basis. Prior to becoming a member of Gavi, she held small business development, strategic marketing and advertising and income roles at Merck & Company and Dynavax Systems, supporting the vaccine and respiratory groups, as perfectly as vaccine candidates including Heplisav-B ®. Ms. Malhame holds an MBA from Cornell College and a Bachelor of Arts diploma in Economics & Global Affairs from Lafayette College.

Ms. Malhame additional, “I am delighted to be signing up for the PharmaJet firm and appear forward to bringing my capabilities and skills to an previously talented leadership group, increasing the use of the PharmaJet technological know-how globally.”

For a lot more information about PharmaJet check out www.pharmajet.com.

About PharmaJet

PharmaJet’s mission is globally acceptance of PharmaJet Needle-no cost Injection Techniques as a standard of care in the vaccine supply current market. The PharmaJet Needle-absolutely free Devices are safe and sound, speedy and uncomplicated-to-use. They do away with needlestick injuries, needle reuse and cross contamination, and support minimize sharps waste disposal. The Stratis ® Method has U.S. Food and drug administration 510(k) marketing clearance, CE Mark and WHO PQS certification to produce medicines and vaccines possibly intramuscularly or subcutaneously. The Tropis ® Program has CE Mark and WHO PQS certification for intradermal injections. For additional details pay a visit to www.pharmajet.com.

Check out source variation on businesswire.com:https://www.businesswire.com/information/house/20200929005003/en/

Call: Nancy Lillie

[email protected]

1-888-900-4321 Solution 3

Search term: COLORADO UNITED STATES NORTH The us

Industry Keyword: BIOTECHNOLOGY Medical Products INFECTIOUS Conditions Wellness PHARMACEUTICAL

Source: PharmaJet

Copyright Business enterprise Wire 2020.

PUB: 09/29/2020 10:10 AM/DISC: 09/29/2020 10:10 AM

http://www.businesswire.com/news/dwelling/20200929005003/en